Retatrutide
A triple-receptor peptide investigated in advanced metabolic studies.
- ✓Independently tested — COA with every order
- ✓Discreet, flat-$20 shipping · SMS + email tracking
- ✓Ships in 1–2 business days once payment clears
Overview
Retatrutide is a newer peptide studied as a triple-pathway approach to metabolism — building on GLP-1 and GIP signaling by adding a third, glucagon-based mechanism tied to energy expenditure. People explore it as part of an ambitious weight and metabolic program.
Maddox Retatrutide is a high-purity, independently tested formulation delivered by injection. It appeals to those following the research on next-generation metabolic compounds who want a rigorously tested source.
Three pathways, one metabolic focus.
What people look to retatrutide to support:
Appetite regulation
GLP-1 and GIP activity reinforce the body's natural fullness and hunger signals.
Energy expenditure
The added glucagon pathway is studied for its role in how the body uses stored energy.
Glucose handling
Supports glucose-dependent insulin signaling for steadier day-to-day energy.
Metabolic breadth
A triple-receptor design studied for combined effects across appetite and energy balance.
How it works
Retatrutide is a triple agonist at the GIP, GLP-1, and glucagon receptors. The GLP-1 and GIP arms support appetite and glucose signaling much like related peptides, working with cues your body already sends.
The distinguishing piece is glucagon-receptor activity, which research connects to energy expenditure and how the body mobilizes stored fuel. Together these three pathways are what make retatrutide a compound of active study.
How to use
- 1
Reconstitute
Add bacteriostatic water down the side of the vial and swirl gently until the solution is fully clear — never shake.
- 2
Dose
Dosing should be set with a healthcare provider based on your goals and health history — protocols are individualized and not something to self-direct.
- 3
Administer
Administration should be demonstrated and directed by a healthcare provider familiar with your protocol.
- 4
Store
Refrigerate reconstituted vials, keep them out of light, and use within the window your provider recommends.
Independently tested, every batch
Every lot is tested by an independent lab and ships with a certificate of analysis, so what's on the label is what's in the vial.
Safety & important considerations
- Talk with a qualified healthcare provider before starting, particularly given how new this compound is.
- The most common effects reported are mild and digestive, often easing as the body adjusts to a gradual dose.
- Not a substitute for professional medical care, nutrition, or movement.
- Stop and seek care if you experience any reaction that concerns you.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Frequently asked questions
What makes retatrutide a 'triple' agonist?＋
It acts on three receptors — GLP-1, GIP, and glucagon — where most related peptides act on one or two. The glucagon pathway is tied to energy expenditure.
How new is retatrutide?＋
It's a newer compound, with evidence coming largely from early clinical and preclinical work, so a cautious, provider-guided approach matters.
How is it taken?＋
Typically a once-weekly subcutaneous injection, with dose and schedule set by your provider.
Why do protocols start so low?＋
A slow ramp helps the body adjust and keeps digestive effects milder. Your provider guides the pace.
Is it independently tested?＋
Yes — every batch is third-party tested for purity and identity before shipping.
Ready to start?
Not sure if Retatrutide is the right fit? Take the quick quiz, or add it to your cart and check out securely.